Figure 1. Acute myeloid leukemia age-specific incidencerates: 19982002 (NCI-SEER Program).*所有药物均需进入细胞内才发挥作用,均具有单细胞杀伤功能;+对人体均具有免疫原性Antibody-dependent cell-mediated cytotoxicity (ADCC)Apoptosis Complement-dependent cytolysis (CDC)CD 52MabCampath&用于成像和放射性剂量计算;*4种不同的Figure 2. Current cooperative group phase III studies ofgemtuzumab ozogamicin (GO) in acute myeloid leukemia (AML).